Skip to main content

Table 3 Baseline characteristics (n = 220)

From: Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis

Female

121 (55%)

Age (years)

54 (13)

Education level, n (%)

 

 High

140 (64%)

 Low

80 (36%)

Resident in Amsterdam, n (%)

99 (45%)

Diagnosis

 

 Rheumatoid arthritis

99 (45%)

 Psoriatic arthritis

81 (37%)

 Ankylosing spondylitis

40 (18%)

Charlson Comorbidity Index

2.3 (1,2)

Disease duration in years, median (IQR)

9 (3–19)

Biological usage, n (%)

 

 b/tsDMARD

111 (50%)

 csDMARD only

109 (50%)

RAPID3 baseline, median (IQR)

3.7 (1.6–5.2)

Medication adherence, n (%)*

 

 High

115 (53%)

 Low

102 (46%)

Smartphone usage (1–10)*

4 (2)

Self-management (1–100)*

76 (12)

Patient-physician Interaction (1–25)*

21 (3)

  1. IQR Inter-quartile range; b/tsDMARD biological/targeted synthetic Disease-Modifying Antirheumatic Drugs; RAPID3 Routine Assessment of Patient Index Data 3
  2. *n = 217. Units are presented as the mean with standard deviation, or otherwise specified